CMEA Capital caters seed, early, and later stage venture, private equity, and debt financing investments and is based in California.
Business Model:
Revenue: $14.1M
Employees: 2-10
Address: 1 Letterman Dr
City: San Francisco
State: CA
Zip: 94129
Country: US
CMEA closed in April of 2015 and has unveiled its new corporate identity as [Presidio Partners](https://www.crunchbase.com/organization/presidio-partners). CMEA Capital is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. We believe that the most successful venture backed companies are those that are science based, with experienced teams that have a vision. As a result, CMEA typically invests in companies that have cutting edge and highly differentiated technology at their core and founding teams of the highest caliber still in place. These are companies that have the potential to transform their industries. CMEA Capital was founded in 1989 and maintains offices in San Francisco and Menlo Park. We invest in both early and late stage science-focused ventures, and leverage a strong network of corporate, investment, and entrepreneurial relationships on behalf of portfolio companies. Our partners and associates have extensive science, engineering, and operational backgrounds, providing us the confidence to look beyond today&s;s technology. We apply our focus on science and teams to our collaborations with entrepreneurs and venture investment partners who are changing the world, one great company at a time.
Contact Phone:
+14153521520
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2007 | Liveops | Series C | 28M |
7/2009 | Schooner Information Technology | Series B | 20M |
12/2010 | Multigig | Series C | 10M |
4/2012 | WorkingPoint | Venture Round | 188k |
3/2008 | NuScale Power | Venture Round | 2.6M |
8/2011 | Ardelyx | Series B | 30M |
1/2007 | Telsima | Venture Round | 50M |
5/2014 | Sorbent Therapeutics | Series D | 0 |
6/2011 | Sorbent Therapeutics | Series B | 0 |
4/2013 | Spitfire Pharma | Venture Round | 0 |
12/2005 | Agility Design Solutions | Series B | 7M |
12/2009 | Danotek Motion Technologies | Venture Round | 13.2M |
9/2010 | Sorbent Therapeutics | Series B | 0 |
8/2006 | Codexis | Series D | 0 |
12/2008 | Contour Energy | Series A | 10.8M |
8/2008 | Triporati | Venture Round | 6M |
9/2011 | Blekko | Venture Round | 30M |
4/2012 | Bionic Panda Games | Venture Round | 800k |
1/2006 | Perlegen Sciences | Series D | 0 |
2/2005 | Perlegen Sciences | Series D | 0 |
9/2011 | Beautylish | Angel Round | 1M |
10/2005 | Raven Biotechnologies | Series D | 48.3M |
1/2009 | Intermolecular | Series D | 20M |
1/2009 | Superprotonic | Series C | 8M |
10/2011 | Contour Energy | Series C | 20M |
8/2008 | Tetraphase Pharmaceuticals | Series A | 0 |
7/2006 | Ambrx | Series C | 52M |
7/2010 | Luminate | Series B | 12M |
8/2011 | Danotek Motion Technologies | Series B | 15M |
12/2005 | Telsima | Series C | 20M |
8/2008 | Schooner Information Technology | Series A | 15M |
9/2007 | Netbooks | Series A | 6.9M |
3/2007 | Phenomix | Series C | 55M |
4/2007 | Mojo Networks | Series C | 0 |
5/2015 | VYNE Therapeutics | Series A | 14.3M |
12/2008 | Symwave | Series C | 10.2M |
7/2008 | Amitive | Series A | 10M |
4/2009 | Pyxis Technology | Series C | 3M |
6/2006 | Pyxis Technology | Series B | 9.2M |
2/2012 | Luminate | Series C | 10.7M |
11/2013 | MediaSpike | Series A | 5.2M |
4/2008 | SpikeSource | Series C | 20M |
3/2014 | Neos Therapeutics | Series C | 15.5M |
11/2012 | Auspex Pharmaceuticals | Series D | 0 |
10/2010 | Auspex Pharmaceuticals | Series C | 12M |
1/2014 | Auspex Pharmaceuticals | Series E | 0 |
6/2010 | Baxano | Series C | 30M |
12/2008 | Solyndra | Series E | 220M |
9/2000 | Sanera Systems | Series A | 17.5M |
3/2002 | Sanera Systems | Venture Round | 10M |
2/2008 | TrueDemand Software | Series C | 2.7M |
7/2007 | Cnano Technology | Series A | 6M |
7/2009 | Intellikine | Series B | 51M |
10/2006 | Strix Systems | Series G | 7M |
3/2013 | RSI (Reel Solar Inc) | Seed Round | 4M |
3/1997 | Silicon Spice | Series A | 3.3M |
10/2001 | Sanera Systems | Series B | 38.3M |
2/2010 | Contour Energy | Series B | 14.2M |
11/2009 | Blekko | Series C | 2.5M |
6/2005 | Intermolecular | Series B | 10.1M |
9/2006 | Intermolecular | Series C | 27.6M |
3/2009 | Luminate | Series A | 5.8M |
7/2012 | MediaSpike | Seed Round | - |
6/2010 | Tetraphase Pharmaceuticals | Series C | 0 |
4/2005 | Teros | Series D | 0 |
10/2011 | Zaarly | Series A | 14.2M |
3/2008 | Luminus Devices | Series E | 72M |
4/2004 | Liveops | Series B | 22M |
11/2008 | Evolution Robotics | Series B | 13.9M |
8/2000 | Syrrx | Series A | 5.1M |
12/2004 | Intermolecular | Series A | 424k |
2/2006 | AWR Corporation | Venture Round | 0 |
11/2006 | Alien Technology | Venture Round | 50M |
5/2008 | Multigig | Series B | 12.5M |
5/2011 | Jobvite | Series C | 15M |
8/2006 | TrueDemand Software | Series B | 8M |
4/2015 | Cnano Technology | Series B | 0 |
10/2014 | Jobvite | Series D | 0 |
7/2013 | Mojo Networks | Series D | 0 |
12/2009 | Solaria | Debt Financing | 0 |
12/2007 | Jobvite | Series A | 7.2M |
7/2009 | Blekko | Series C | 11.5M |
12/2006 | Untangle | Series A | 10.5M |
5/2008 | Untangle, Inc. | Series B | 8M |
5/2009 | Visiogen | Series D | 40M |
9/2009 | Jobvite | Series B | 8.3M |
12/2011 | Graffiti Labs | Seed Round | 1.6M |
4/2009 | Ambrx | Series D | 10M |
5/2014 | Arcadia Biosciences | Series D | 0 |
6/2008 | Ardelyx | Series A | 26.1M |
11/2006 | Kalypsys | Series C | 100M |
2/2008 | InSound Medical | Series E | 11M |
11/2008 | Danotek Motion Technologies | Series A | 14.5M |
10/2009 | Foro Energy | Venture Round | 25M |
1/2010 | Cnano Technology | Series B | 7M |
10/2007 | Relypsa | Series A | 33M |
5/2015 | VYNE Therapeutics | Series A | 0 |
4/2015 | Cnano Technology | Series B | 0 |
10/2014 | Jobvite | Series D | 0 |
5/2014 | Sorbent Therapeutics | Series D | 0 |
5/2014 | Arcadia Biosciences | Series D | 0 |
3/2014 | Neos Therapeutics | Series C | 0 |
1/2014 | Auspex Pharmaceuticals | Series E | 0 |
11/2013 | MediaSpike | Series A | 0 |
7/2013 | Mojo Networks | Series D | 0 |
4/2013 | Spitfire Pharma | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|